Pharmaceutical Commerce - January/February 2014 - (Page 6)

Table of Contents 4 editorial DQSA: a bargain for the life sciences industry The Drug Quality and Security Act will change industry for the better 7 Op-ed Top health industry issues for life sciences in 2014 PwC's annual forecast of the year's most important healthcare trends networking for life science logistics The Health & Personal Care Logistics Conference brings industry leaders together 8 Top news Cardinal Health repeats as no. 1 organization in Gartner healthcare supply chain rankings Annual Cegedim survey finds emphasis on changing commercial models Multichannel marketing is high in attention, but low on execution; Docnet will be a new social media platform Drug Quality and Security Act becomes law Long-awaited track-and-trace law ushers in a new era of pharmaceutical supply-chain monitoring; compounding pharmacies get a new structure also Walgreens combines operations with CareMetx to address specialty-patient hub services Walgreens' Pharma Dynamics subsidiary will be merged into CareMetx Contract administration software market heats up with new offerings Both Revitas and Model N bring out enhanced scriptvalidation modules to ensure rebate accuracy 16 brand Marketing & Communications Promotional experimentation and consumer outreach will be available via the Truvio network New service launched by WEGO Health offers rapid feedback from key opinion influencers in consumer healthcare Copay programs' increased value to manufacturers is matched by rising criticism Despite proven medical value, coupon and copay offset programs continue to draw fire from insurers; meanwhile, will the programs extend to ACA insureds? 18 Supply Chain/Logistics Air carriers double down on winning business from life sciences Rising production and trade, along with tightening regulations, make life sciences an attractive target for air cargo and logistics services 20 Legal & regulatory Finding the value in outsourced contract administration The growing complexity of managed-markets contract support makes outsourcing a near-necessity for Small Pharma, and a better option for Big Pharma 21 Information Technology Full-line distributor sales topped $300 billion in 2012, representing 91% of pharma sales HDMA's 2013-14 Factbook updates member financial, operational performance ValueCentric updates its flagship IT service, ValueTrak, with advanced data-visualization capabilities Finance, marketing and other nontraditional users find value in the company's sales and inventory data Cold Chain Technologies upgrades materials, insulation for temperature-controlled packaging New KoolTemp GTS parcels have higher performance and lower cost and weight Cloud computing and big Data will dominate IT healthcare trends in 2014 Liaison Healthcare Informatics predicts trends for healthcare and life sciences Industry group rx-360 lays plans for expanding activities in China An inaugural planning meeting was held in November; meanwhile China cracks down on online sales Consulting firm puts compliance front and center for clinical-stage drug developers New "emergent biopharma" service combines compliance with pricing, market access QPharma offers QLaunch advisory service 12 business/Finance A conversation with Peyton Howell, Amerisourcebergen HDMA looks closely at 'buy and bill' in specialty pharma distribution Will 'white bagging' and specialty-pharmacy business practices change distribution dynamics? IMS Institute projects global pharma market of $1.17-1.20 trillion in 2017 Growth includes 1-4% CAGR in US, 0-3% in Europe and 14-17% in China. US specialties have a twist 22 Manufacturing & Packaging The role of labels in patient safety Advanced label technologies serve functions far beyond product identification PCI breaks ground on new clinical storage and distribution facility Contract packager addresses growing clinical-products business reminder packaging is a "consistently effective medication-adherence intervention strategy," says Decision resources Analysts find that better adherence can be a competitive advantage in new-product introductions educating patients on self-administered drug injections The trend toward self-administered drugs creates a pressing need for better patient-education resources 26 Company Profiles Section 2014 Pharmaceutical Commerce Category Leaders 31 6 Visit our website at January | February 2014 Meetings and editorial Index VOL. 9, NO. 1 Founder and editor in Chief Nicholas Basta, 718 282 6112 Contributing editors Lena Anthony, F.J. Quinn, Bob Sperber, Suzanne Shelley, Peggy Wright editorial board Jeffrey Berkowitz, Walgreens Richard Carlson, Blue Fin Group Liz Coyle, IMS Health Adam Fein, Pembroke Consulting Rich Minoff, 1 Global Partners Mark Seitz, Eli Lilly & Co. Robert Zachow, Bracco Diagnostics Advertising Sales Senior Vice President and Publisher Clifford P. Tallman, Jr., 203 831 0771 new england Vince Cavaseno, 617 232 2000 Jody Estabrook, 774 283 4528 Midwest David Gerchen, 314 878 3939 Southeast Cathy Williams, 843 410 2739, ext. 101 West Richard Ayer, 949 366 9089 Advertising and editorial Production Advertising: Heidi Nelson, 203 852 6570, ext. 228 Editorial Layout: Media Ventures, Inc. Circulation and Administration Senior Vice President and General Manager David Soskin, 203 831 0711 reprints, research and Custom Publishing David Soskin, 203 831 0711 Circulation Subscription Changes Jennifer Lee Healthcare Commerce Media Corporation Pharmaceutical Commerce is published by Healthcare Commerce Media Corp. 85 Westminster Rd., Brooklyn, NY 11218. editorial/Advertising Queries: 718 282 6112, or Copyright 2014. All rights reserved. Printed in the United States of America. Send all subscription inquiries or requests to Subscriptions, Pharmaceutical Commerce, 151 Fairchild Avenue, Plainview, NY 11808-1709, Tel: 800 437 7456. Fax: 516 908 3802 The management and editors of Pharmaceutical Commerce make every effort to publish accurate information. However, neither the management, editorial board, editors or reporters can be held liable for erroneous information. Opinions of Pharmaceutical Commerce columnists are their own, and do not necessarily represent those of employees or other contributors to Pharmaceutical Commerce.

Table of Contents for the Digital Edition of Pharmaceutical Commerce - January/February 2014

Table of Contents

Pharmaceutical Commerce - January/February 2014